Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report.
作者信息
Borrego Izquierdo Yolanda, López Briz Eduardo, Márquez Saavedra Esther
机构信息
Hospital Universitario Nuestra Señora de Valme. Sevilla..
Hospital Universitario y Politécnico La Fe. Valencia. España..
出版信息
Farm Hosp. 2015 Jan 1;39(1):1-5. doi: 10.7399/fh.2015.39.1.8581.
PMID:25680429
Abstract
摘要
相似文献
1
Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report.贝达喹啉用于耐多药肺结核的GENESIS-SEFH药物评估报告。
Farm Hosp. 2015 Jan 1;39(1):1-5. doi: 10.7399/fh.2015.39.1.8581.
2
Bedaquiline.贝达喹啉
Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2.
3
Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.对抗耐药结核病：贝达喹啉的意外益处
Int J Tuberc Lung Dis. 2017 Jan 1;21(1):4-5. doi: 10.5588/ijtld.16.0768.
4
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.贝达喹啉在儿童和青少年耐多药结核病中的超说明书使用。
Emerg Infect Dis. 2017 Oct;23(10):1711-3. doi: 10.3201/eid2310.170303. Epub 2017 Oct 17.
5
TMC207 becomes bedaquiline, a new anti-TB drug.TMC207 变成贝达喹啉，一种新的抗结核药物。
Future Microbiol. 2013 Sep;8(9):1071-80. doi: 10.2217/fmb.13.85.
6
Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls.用于治疗耐药结核病的贝达喹啉：前景与陷阱
Tuberculosis (Edinb). 2014 Jul;94(4):357-62. doi: 10.1016/j.tube.2014.04.001. Epub 2014 Apr 18.
7
Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.贝达喹啉作为成人耐多药肺结核联合治疗方案的一部分。
Expert Rev Clin Pharmacol. 2016 Aug;9(8):1025-37. doi: 10.1080/17512433.2016.1200462. Epub 2016 Jun 27.
8
Bedaquiline. More data needed on this dangerous antitubercular drug.贝达喹啉。关于这种危险的抗结核药物，还需要更多数据。
Prescrire Int. 2014 Oct;23(153):232-4.
9
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review.贝达喹啉与地拉曼尼联合治疗耐多药结核病：一项系统评价
Eur Respir J. 2018 Jul 4;52(1). doi: 10.1183/13993003.00934-2018. Print 2018 Jul.
Zotero 插件